Dataset from Trial Consisting of an 8-week Double-blind Placebo-controlled Part to Evaluate Efficacy, Safety, Tolerability and Pharmacokinetics of Prucalopride in Paediatric Subjects With Functional Constipation, Aged ≥6 Months to <18 Years, Followed by a 16-week Open-label Comparator (PEG) Controlled Part, to Document Safety and Tolerability up to 24 Weeks
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00006719
下载链接
链接失效反馈官方服务：
资源简介：
To evaluate the efficacy of prucalopride compared to placebo for the treatment of functional
constipation in a paediatric population, aged ≥ 6 months to < 18 years. A 16-week open-label
comparator (PEG) controlled part will follow, to document safety and tolerability up to 24
weeks.
创建时间：
2024-11-26
